- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Fatty Liver in United States
Total 4366 results
-
Cirius Therapeutics, Inc.Chiltern International Inc.CompletedNon-alcoholic Fatty Liver Disease | NASH - Nonalcoholic Steatohepatitis | Non-alcoholic SteatohepatitisUnited States
-
Galmed Research and Development, Ltd.SuspendedNonalcoholic Steatohepatitis (NASH)United States
-
Newcastle-upon-Tyne Hospitals NHS TrustNewcastle UniversityCompletedNonalcoholic SteatohepatitisUnited Kingdom
-
University of OxfordCompletedNAFLD | Fat; LiverUnited Kingdom
-
Columbia UniversityCompletedInsulin Resistance | Dyslipidemias | HyperinsulinemiaUnited States
-
Stanford UniversityCompletedLiver Cirrhosis | Liver SteatosesUnited States
-
Imperial College LondonEnrolling by invitationCardiovascular Diseases | Diabetes | Respiratory Disease | Non-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
Mirum Pharmaceuticals, Inc.TerminatedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, Canada, Puerto Rico
-
Yaqrit LtdAssistance Publique - Hôpitaux de Paris; IRCCS Azienda Ospedaliero-Universitaria... and other collaboratorsWithdrawnNon-Alcoholic SteatohepatitisFrance, Italy, Portugal, Spain, Switzerland, United Kingdom
-
Lidia SzczepaniakForest LaboratoriesCompleted
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedDiabetes Mellitus, Type 2 | NAFLD | Hypertriglyceridemia | Fatty Liver, NonalcoholicUnited States, Canada
-
Johns Hopkins UniversityResMed FoundationCompletedObstructive Sleep Apnea | Non Alcoholic Fatty Liver DiseaseUnited States
-
Hanmi Pharmaceutical Company LimitedRecruitingNASH - Nonalcoholic SteatohepatitisKorea, Republic of, United States
-
Merck Sharp & Dohme LLCTerminatedNonalcoholic SteatohepatitisKorea, Republic of, United States, Argentina, Australia, Canada, Chile, China, Colombia, France, Germany, Greece, Hong Kong, Israel, Italy, Japan, Malaysia, Mexico, New Zealand, Puerto Rico, Russian Federation, Spain, Sweden, Taiwan, ...
-
Astellas Pharma IncCompletedNon-Alcoholic SteatohepatitisUnited Kingdom, Belgium, Switzerland, Germany, France, Romania, Czech Republic
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Fatty LiverUnited States
-
Immuron Ltd.CompletedNon-alcoholic Steatohepatitis (NASH)United States, Australia, Israel
-
Altimmune, Inc.RecruitingNon-Alcoholic Steatohepatitis (NASH)Australia, United States, Puerto Rico
-
Novo Nordisk A/SActive, not recruitingNon-alcoholic SteatohepatitisSpain, Denmark, Taiwan, Korea, Republic of, Australia, Canada, India, Singapore, United States, Turkey, Poland, Italy, Belgium, Puerto Rico, United Kingdom, Malaysia, Germany, Portugal, Bulgaria, Czechia, France, Greece, Japan, Russian...
-
Viking Therapeutics, Inc.CompletedNAFLD | HyperlipidemiaUnited States
-
University of Alabama at BirminghamCompletedInsulin Resistance | Non-alcoholic Fatty Liver Disease | Childhood ObesityUnited States
-
University of PittsburghTerminatedNonalcoholic Steatohepatitis | Post Liver Transplantation Weight Gain | Post Liver Transplantation ObesityUnited States
-
89bio, Inc.RecruitingMetabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisUnited States
-
Children's Hospital Medical Center, CincinnatiTerminated
-
Genentech, Inc.CompletedDiabetes Mellitus, Type 2 | Non-Alcoholic Fatty Liver DiseaseUnited States, Canada
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingObesity | Diabetes Mellitus, Type 2 | Insulin Resistance | PreDiabetes | Diet Modification | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
Corcept TherapeuticsCompletedNon-alcoholic Steatohepatitis (NASH) | Antipsychotic Induced Weight GainUnited States
-
Sonic IncytesCompletedLiver Steatosis | Liver FibrosisUnited States, Canada
-
Andres Duarte-RojoCompletedLiver Disease | Early Allograft Dysfunction | Liver Steatosis | Liver Transplant | Primary Non-functionUnited States
-
NorthSea Therapeutics B.V.Active, not recruitingNon Alcoholic Steatohepatitis (NASH)United States, Puerto Rico
-
NGM Biopharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
University of IowaRecruiting
-
United Arab Emirates UniversityTawam HospitalCompletedCompensated Cirrhosis | Non-alcoholic Fatty Liver | Esophageal VaricesUnited Arab Emirates
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)Canada, United States, Hong Kong, United Kingdom, Switzerland, New Zealand
-
Zydus Therapeutics Inc.RecruitingNonalcoholic SteatohepatitisUnited States
-
Metacrine, Inc.Active, not recruitingDiabetes | Fatty Liver | Type 2 Diabetes | NAFLD | NASH - Nonalcoholic Steatohepatitis | Diabetes Type 2 | NASH | Fatty Liver, NonalcoholicUnited States
-
Enanta Pharmaceuticals, IncTerminatedNon-Alcoholic SteatohepatitisUnited States, Canada, Puerto Rico, United Kingdom, Argentina, Germany
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Duke...Recruiting
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisUnited States, Spain, Hong Kong, Canada, Belgium, Australia, Taiwan, India, Japan, Korea, Republic of, Singapore, United Kingdom, Israel, Puerto Rico, France, New Zealand, Germany, Austria, Italy, Mexico, Poland, Switzerland
-
New Discovery LLCNYU Langone Health; Stanford University; Baylor University; Rush University; Wuxi...RecruitingFatty Liver | Liver FibrosisUnited States
-
Boehringer IngelheimRecruitingObesity | Non-alcoholic Fatty Liver DiseaseUnited States
-
Enanta Pharmaceuticals, IncICON Clinical Research; Triangle BiostatisticsCompletedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, New Zealand, Canada, France, Puerto Rico
-
Indiana University School of MedicineTerminatedHIV Infections | NAFLD | NASH - Nonalcoholic SteatohepatitisUnited States
-
NGM Biopharmaceuticals, IncCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
-
AstraZenecaParexelCompletedMetabolic Disorders | Non-alcoholic SteatohepatitisUnited States
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
Regeneron PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis (NASH)Brazil, United States, Puerto Rico, Korea, Republic of, Mexico
-
University of FloridaTerminatedObesity | Diabetes Mellitus, Type 2 | NAFLDUnited States
-
Tobira Therapeutics, Inc.TerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Australia, France, Germany, Spain, Poland, United Kingdom, Italy, Puerto Rico, Belgium, Hong Kong
-
Manchester University NHS Foundation TrustUniversity of Nottingham; University of Manchester; Innovate UKRecruitingAlcoholic Liver Disease | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Liver FibrosesUnited Kingdom